Press Releases

MGEN $2.95 $ + 0.04 (1.37%)

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
1/10/2019
7:00 AM ET
Press Release

miRagen Announces New Clinical Data in Patients With Three Different Types of Blood Cancers Treated With Cobomarsen

1/10/2019

50% of cutaneous T-cell lymphoma patients treated with 300mg IV infusion achieved objective response lasting for greater than four months (ORR4)Evidence of disease stabilization in five adult T-cell l...

 Continue Reading
12/20/2018
7:00 AM ET
Press Release

miRagen Therapeutics to Present New Cobomarsen Clinical Trial Data for Adult T-Cell Leukemia/Lymphoma and Cutaneous T-Cell Lymphoma at the 11th Annual T-Cell Lymphoma Forum

12/20/2018

BOULDER, Colo., Dec. 20, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted thera...

 Continue Reading
12/5/2018
4:05 PM ET
Press Release

miRagen Therapeutics Announces Board of Director Evolution and Appointment of New Chairman

12/5/2018

BOULDER, Colo., Dec. 05, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted thera...

 Continue Reading
12/2/2018
5:00 PM ET
Press Release

miRagen Therapeutics Announces Final Safety, Biodistribution and Clinical Efficacy Data From Phase 1 Cobomarsen Clinical Trial in Patients With Mycosis Fungoides

12/2/2018

BOULDER, Colo., Dec. 02, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted thera...

 Continue Reading
11/7/2018
4:01 PM ET
Earnings Release

miRagen Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update

11/7/2018

Continued advancements of three clinical stage microRNA-targeted product candidates currently being evaluated for multiple potential indications in four clinical trialsGlobal Phase 2 SOLAR clinical tr...

 Continue Reading
Displaying 1 to 5 (of 69 releases)